Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
AKA - a.k.a. Brands Holding Corp - Stock Price Chart
TickerAKA [NYSE]
Companya.k.a. Brands Holding Corp
CountryUSA
IndustryInternet Retail
Market Cap274.68MEPS (ttm)-9.21
P/E-EPS this Y82.28%
Forward P/E-EPS next Y29.16%
PEG-EPS past 5Y-
P/S0.51EPS next 5Y-
P/B2.03EPS Q/Q4.42%
Dividend-Sales Q/Q-3.03%
Insider Own91.51%Inst Own0.38%
Insider Trans0.00%Inst Trans28.45%
Short Float7.59%EarningsMay 08/a
Analyst Recom2.60Target Price22.50
Avg Volume8.23K52W Range3.81 - 33.73
a.k.a. Brands Holding Corp. engages in the provision of a portfolio of online fashion products through its digital platform. It operates through the Online and Stores business segments. The Online segment offers fashion products through Culture Kings. The Stores segment provides retail services. The company was founded on May 19, 2021 and is headquartered in San Francisco, CA.
CGEM - Cullinan Therapeutics Inc - Stock Price Chart
TickerCGEM [NASD, RUT]
CompanyCullinan Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.03BEPS (ttm)-3.14
P/E-EPS this Y17.92%
Forward P/E-EPS next Y-0.88%
PEG-EPS past 5Y-62.42%
P/S-EPS next 5Y-
P/B2.41EPS Q/Q39.38%
Dividend-Sales Q/Q-
Insider Own46.44%Inst Own60.54%
Insider Trans-0.98%Inst Trans-1.51%
Short Float10.21%EarningsMay 15/a
Analyst Recom1.00Target Price33.00
Avg Volume737.42K52W Range7.64 - 30.19
Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Michaelson JenniferChief Scientific OfficerMay 07 '24Option Exercise4.305,60624,106135,188May 08 07:30 PM
Michaelson JenniferChief Scientific OfficerMay 07 '24Sale30.065,606168,516129,582May 08 07:30 PM
Michaelson JenniferChief Scientific OfficerMay 06 '24Option Exercise4.3050,000215,000187,582May 08 07:30 PM
Michaelson JenniferChief Scientific OfficerMay 06 '24Sale28.0758,0001,628,159129,582May 08 07:30 PM
Savill CorrineChief Business OfficerFeb 01 '24Option Exercise4.3040,000172,000205,990Feb 02 09:35 PM
EFOI - Energy Focus Inc - Stock Price Chart
TickerEFOI [NASD]
CompanyEnergy Focus Inc
CountryUSA
IndustryFurnishings, Fixtures & Appliances
Market Cap8.14MEPS (ttm)-0.98
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y45.11%
P/S1.45EPS next 5Y35.00%
P/B2.52EPS Q/Q83.66%
Dividend-Sales Q/Q-10.43%
Insider Own35.69%Inst Own0.92%
Insider Trans0.00%Inst Trans-76.48%
Short Float1.04%Earnings-
Analyst Recom3.00Target Price42.00
Avg Volume255.54K52W Range1.20 - 3.66
Energy Focus, Inc. engages in the design, development, manufacture, and marketing of lighting systems and controls. The company was founded in 1985 and is headquartered in Solon, OH.
MMA - Alta Global Group Ltd. - Stock Price Chart
TickerMMA [AMEX]
CompanyAlta Global Group Ltd.
CountryAustralia
IndustryLeisure
Market Cap44.98MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float0.09%Earnings-
Analyst Recom-Target Price-
Avg Volume39.73K52W Range2.87 - 5.25
Alta Global Group Ltd. operates as a physical fitness center. It provides technology enabled combat fitness training to the everyday person both in gym and at home. The firms products include Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community. The company was founded by James Fleet, Nick Langton, John Kavanagh and Conor McGregor on March 27, 2013 and is headquartered in Sydney, Australia.
XBIO - Xenetic Biosciences Inc - Stock Price Chart
TickerXBIO [NASD]
CompanyXenetic Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap5.47MEPS (ttm)-2.92
P/E-EPS this Y-39.13%
Forward P/E-EPS next Y23.96%
PEG-EPS past 5Y51.08%
P/S2.24EPS next 5Y-
P/B0.63EPS Q/Q-37.34%
Dividend-Sales Q/Q-15.69%
Insider Own18.58%Inst Own1.27%
Insider Trans0.00%Inst Trans-29.84%
Short Float0.50%EarningsMay 10/b
Analyst Recom3.00Target Price40.00
Avg Volume5.59K52W Range2.55 - 5.97
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient's malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.
TAIT - Taitron Components Inc. - Stock Price Chart
TickerTAIT [NASD]
CompanyTaitron Components Inc.
CountryUSA
IndustryElectronics & Computer Distribution
Market Cap17.28MEPS (ttm)0.27
P/E10.59EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y4.85%
P/S3.46EPS next 5Y-
P/B1.01EPS Q/Q-27.55%
Dividend6.97%Sales Q/Q-53.84%
Insider Own47.30%Inst Own14.99%
Insider Trans0.00%Inst Trans10.09%
Short Float0.13%Earnings-
Analyst Recom-Target Price-
Avg Volume10.16K52W Range3.05 - 4.32
May-16-24 08:53AM TAIT Stock Earnings: Taitron Components Reported Results for Q1 2024 (InvestorPlace) -10.17%
May-03-24 04:05PM Taitron Announces Quarterly Cash Dividend (GlobeNewswire)
Apr-08-24 12:52PM TAIT Stock Earnings: Taitron Components Reported Results for Q4 2023 (InvestorPlace)
Mar-31-24 08:35AM 13 High-Dividend Stocks to Invest In Under $10 (Insider Monkey)
Feb-14-24 03:10AM Jim Simons Adjusts Position in Taitron Components Inc (GuruFocus.com)
Feb-02-24 04:05PM Taitron Announces Quarterly Cash Dividend (GlobeNewswire)
Oct-27-23 04:05PM Taitron Announces Quarterly Cash Dividend (GlobeNewswire)
Aug-02-23 02:56PM Taitron Components (NASDAQ:TAIT) Shareholders Will Want The ROCE Trajectory To Continue (Simply Wall St.)
Jul-28-23 04:05PM Taitron Announces Quarterly Cash Dividend (GlobeNewswire)
Jul-10-23 08:42PM Surprise! These 3 Penny Stocks Pack Powerful Financials. (InvestorPlace)
Taitron Components, Inc. engages in the manufacture and distribution of original designed and manufactured products and electronic components. It also offers discrete semiconductors and commodity integrated circuits, optoelectronic devices, passive components, and value-added engineering and turnkey services. The company was founded by Stewart Wang and Tzu Sheng Ku in 1989 and is headquartered in Valencia, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KU TZU SHENGDirectorOct 09 '23Option Exercise2.431,6674,051688,265Oct 11 05:11 PM
KU TZU SHENGDirectorAug 10 '23Option Exercise2.1223,33349,549686,598Aug 14 06:46 PM
BFRI - Biofrontera Inc - Stock Price Chart
TickerBFRI [NASD]
CompanyBiofrontera Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap5.55MEPS (ttm)-13.10
P/E-EPS this Y74.19%
Forward P/E-EPS next Y83.18%
PEG-EPS past 5Y7.90%
P/S0.17EPS next 5Y-
P/B-EPS Q/Q48.58%
Dividend-Sales Q/Q-9.40%
Insider Own37.89%Inst Own25.69%
Insider Trans0.00%Inst Trans-
Short Float0.75%EarningsMay 15/a
Analyst Recom1.00Target Price16.00
Avg Volume615.06K52W Range0.61 - 13.42
Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company is focused on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.
ELTX - Elicio Therapeutics Inc. - Stock Price Chart
TickerELTX [NASD]
CompanyElicio Therapeutics Inc.
CountryUSA
IndustryBiotechnology
Market Cap95.96MEPS (ttm)-5.79
P/E-EPS this Y51.15%
Forward P/E-EPS next Y1.47%
PEG-EPS past 5Y3.87%
P/S-EPS next 5Y-
P/B19.68EPS Q/Q23.59%
Dividend-Sales Q/Q-
Insider Own23.42%Inst Own4.18%
Insider Trans102.55%Inst Trans-2.78%
Short Float1.09%EarningsMay 15/a
Analyst Recom2.00Target Price10.00
Avg Volume55.45K52W Range2.96 - 24.39
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chudnovsky YekaterinaDirectorDec 22 '23Buy5.811,213,0007,047,5301,915,639Dec 26 04:29 PM
BTCM - BIT Mining Ltd ADR - Stock Price Chart
TickerBTCM [NYSE]
CompanyBIT Mining Ltd ADR
CountryUSA
IndustryInformation Technology Services
Market Cap26.66MEPS (ttm)-1.31
P/E-EPS this Y200.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y31.01%
P/S0.11EPS next 5Y15.75%
P/B0.68EPS Q/Q96.72%
Dividend-Sales Q/Q-82.95%
Insider Own3.15%Inst Own0.51%
Insider Trans0.00%Inst Trans-82.61%
Short Float3.61%EarningsFeb 23/a
Analyst Recom5.00Target Price13.80
Avg Volume141.65K52W Range1.79 - 6.95
BIT Mining Ltd. engages in holding certain digital assets in connection with their cryptocurrency mining business and indirectly holding the equity interest. It operates through the following segments: Mining Pool, Data Center, and Cryptocurrency Mining. The company was founded by Man San Law in 2001 and is headquartered in Akron, OH.
INAB - IN8bio Inc - Stock Price Chart
TickerINAB [NASD]
CompanyIN8bio Inc
CountryUSA
IndustryBiotechnology
Market Cap45.00MEPS (ttm)-1.01
P/E-EPS this Y35.67%
Forward P/E-EPS next Y11.14%
PEG-EPS past 5Y-50.62%
P/S-EPS next 5Y-
P/B1.77EPS Q/Q33.21%
Dividend-Sales Q/Q-
Insider Own32.38%Inst Own26.85%
Insider Trans0.00%Inst Trans-22.21%
Short Float0.60%EarningsMay 09/a
Analyst Recom1.00Target Price7.17
Avg Volume345.13K52W Range0.65 - 3.48
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Graff Jeremy R.DirectorSep 13 '23Buy0.952,5002,3752,500Sep 15 04:51 PM
McCall PatrickChief Financial OfficerAug 25 '23Buy1.031,0001,0306,263Aug 28 04:43 PM
Ho William Tai-WeiPresident and CEOAug 24 '23Buy1.0523,80024,9902,339,545Aug 28 04:42 PM
1234567891020